Shares of Arena Pharmaceuticals jumped 2.14% to $71.71 at 13:22 EST on Tuesday, following yesterday’s upward trend. The Nasdaq Stock Market is jumping 0.67% to $12,523.00, following yesterday’s upward trend, This seems, at the moment, a somewhat positive trend trading session today.

Arena Pharmaceuticals’s last close was $70.21, 25.77% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the present quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value

Arena Pharmaceuticals’s stock is valued at $71.71 at 13:22 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is under its 50-day moving average of $72.64 and higher than its 200-day moving average of $69.30.


Please enter your comment!
Please enter your name here